Hillhouse Capital Group is a leading investment management firm. Founded by Lei Zhang in 2005, Hillhouse invests with a long-term time horizon and employs a fundamental, bottom-up approach. Independent proprietary research is key to our investment process. Our team focuses on the consumer, TMT, industrials and healthcare sectors and invests in companies across all equity stages. Hillhouse manages capital for institutional clients such as university endowments, foundations, sovereign wealth funds, pensions and family offices.
View Top Employees from 高济医药（北京）有限公司| Website | http://www.hillhousecap.com |
| Revenue | $168 million |
| Employees | 413 (413 on RocketReach) |
| Founded | 2005 |
| Address | 900 3rd Ave, New York, New York 10022, US |
| Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
| Industry | Medical Practices, Venture Capital & Private Equity, Hedge Fund, Finance, Private Equity, Venture Capital, Operating Platforms |
| Web Rank | 935556 |
| Keywords | 高瓴资本, Hillhouse Capital, Hillhouse, 高瓴资本集团, Epson_L805 |
| Competitors | Hellman & Friedman, Legacy Partners, Sciens Capital Management, The Riverside Company, Wingate Partners |
| SIC | SIC Code 62 Companies, SIC Code 628 Companies |
| NAICS | NAICS Code 52211 Companies, NAICS Code 522110 Companies, NAICS Code 52 Companies, NAICS Code 5221 Companies, NAICS Code 522 Companies |
Looking for a particular 高济医药（北京）有限公司 employee's phone or email?
高济医药（北京）有限公司 Questions
The 高济医药（北京）有限公司 annual revenue was $168 million in 2023.
Yue QIU is the Vice President of 高济医药（北京）有限公司.
413 people are employed at 高济医药（北京）有限公司.
高济医药（北京）有限公司 is based in New York, New York.
The NAICS codes for 高济医药（北京）有限公司 are [52211, 522110, 52, 5221, 522].
The SIC codes for 高济医药（北京）有限公司 are [62, 628].
Top 高济医药（北京）有限公司 Employees
-
34
-
2
-
2
-
41
-
25
-
44
-
23
Related Companies
